Saudi Central Bank’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.45M Buy
41,989
+13,216
+46% +$780K 0.02% 365
2026
Q2
$1.61M Buy
28,773
+13,791
+92% +$718K 0.02% 378
2026
Q1
$719K Buy
+14,982
New +$656K 0.02% 387
2025
Q2
– Sell
-149
Closed -$4.64K – 448
2025
Q1
$4.64K Buy
+149
New +$4.72K 0.02% 492

Other funds holding RPRX

Saudi Central Bank's RPRX Position: Q3 2026 in Review

Saudi Central Bank increased its Royalty Pharma (RPRX) stake by 46% in Q3 2026, buying an estimated $780K and bringing the position to 41,989 shares worth $2.45M. The position accounts for 0.02% of the portfolio, ranked #365.

Saudi Central Bank first reported a position in RPRX in Q1 2025 and has held it in 4 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Saudi Central Bank held 41,989 shares of Royalty Pharma worth $2.45M as of Q3 2026.
  • Saudi Central Bank bought 13,216 Royalty Pharma shares in Q3 2026, an estimated $780K.
  • Royalty Pharma made up 0.02% of Saudi Central Bank's portfolio in Q3 2026, its #365 holding.
  • Saudi Central Bank first reported a position in Royalty Pharma in Q1 2025 and has held it in 4 quarters since.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Saudi Central Bank's 13F filing for Q3 2026, filed 13 Nov 2026.